TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness, safety, and tolerability (how
well the body stands the drug) of an investigational protease inhibitor (PI) called TMC114
given with low dose ritonavir.